Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $938.9 million.

  • Cellebrite DI's Liabilities and Shareholders Equity rose 3595.38% to $938.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year increase of 3595.69%. This contributed to the annual value of $938.9 million for FY2025, which is 3595.38% up from last year.
  • As of Q4 2025, Cellebrite DI's Liabilities and Shareholders Equity stood at $938.9 million, which was up 3595.38% from $834.3 million recorded in Q3 2025.
  • Over the past 5 years, Cellebrite DI's Liabilities and Shareholders Equity peaked at $938.9 million during Q4 2025, and registered a low of $315.1 million during Q3 2021.
  • For the 5-year period, Cellebrite DI's Liabilities and Shareholders Equity averaged around $532.5 million, with its median value being $503.0 million (2023).
  • As far as peak fluctuations go, Cellebrite DI's Liabilities and Shareholders Equity crashed by 675.22% in 2021, and later surged by 4147.49% in 2025.
  • Over the past 5 years, Cellebrite DI's Liabilities and Shareholders Equity (Quarter) stood at $339.8 million in 2021, then increased by 18.69% to $403.3 million in 2022, then soared by 32.13% to $532.9 million in 2023, then grew by 29.59% to $690.6 million in 2024, then soared by 35.95% to $938.9 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $938.9 million for Q4 2025, versus $834.3 million for Q3 2025 and $787.4 million for Q2 2025.